Diageo Reshapes Its Portfolio: Can Core Brands Drive Growth?

The company is also prioritizing investment behind brands and categories with stronger growth potential. Diageo continues to see long-term opportunity in spirits and RTDs, and plans accelerated investment behind Guinness. At the same time, roughly $1 billion in planned operating-framework and supply-chain savings should create room to fund innovation, strengthen competitiveness and support brand investment without reducing operating profit.

For fiscal 2027, Diageo expects broadly flat organic net sales, with North America down in the mid-single digits, while organic operating profit is projected to grow in the low to mid-single digits. For fiscal 2027-2029, management targets low-single-digit organic sales CAGR, mid-single-digit organic operating profit growth and a cumulative free cash flow of $8 billion, supported by improving North American share trends and cost savings.

The key question is whether tighter portfolio focus, broader activation and stronger execution behind core brands can offset persistent weakness in U.S. spirits, stabilize market share and return Diageo to more consistent sales and profit growth over the medium term, particularly as consumer demand remains uneven across markets.

Zacks Rundown for Diageo

DEO shares have rallied 16.6% in the past three months compared with the industry’s growth of 2.5% and the S&P 500’s return of 1.7%. The Zacks Rank #3 (Hold) company has also outpaced the Consumer Staples sector’s decline of 0.2% in the same period.

Diageo’s 3-Month Price Performance

Image Source: Zacks Investment Research

From a valuation standpoint, DEO is trading at a forward price-to-earnings ratio of 14.61X, lower than the industry’s 15.32X multiple.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Diageo’s fiscal 2027 earnings implies a year-over-year decline of 2.4% and that for fiscal 2028 suggests 4.2% growth. Earnings estimates for fiscal 2027 and 2028 have moved up 1.4% and 1.2% in the past seven days.

Image Source: Zacks Investment Research

Stocks to Consider

The Vita Coco Company Inc. COCO is the leading coconut water brand in the United States, leveraging its strong brand equity, expanding global presence and asset-light business model to capitalize on the growing demand for healthier hydration beverages. COCO currently sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The consensus estimate for Vita Coco’s current fiscal-year sales and earnings implies growth of 31.6% and 64.7%, respectively, from the year-ago reported figures. COCO has delivered a trailing four-quarter earnings surprise of 21.9%, on average.

The Coca-Cola Company KO is a leading beverage company with a portfolio of 32 billion-dollar brands spanning sparkling beverages, water, sports drinks, dairy and value-added beverages. KO currently carries a Zacks Rank #2 (Buy).

The Zacks Consensus Estimate for Coca-Cola’s current fiscal-year sales and earnings implies growth of 3.8% and 9.7%, respectively, from the year-ago reported figures. Coca-Cola delivered a trailing four-quarter earnings surprise of 4.6%, on average.

Primo Brands Corporation PRMB is a leading North American branded beverage company focused on healthy hydration. It currently has a Zacks Rank #2. 

The Zacks Consensus Estimate for Primo Brands’ current fiscal-year sales and earnings indicates growth of 2.6% and 0.8%, respectively, from the prior year’s reported levels. PRMB delivered a trailing four-quarter earnings surprise of 7.7%, on average.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research